VAERS reports by lot

GSK Varicella/Shingles lot P45M9: VAERS reports

71 VAERS reports list lot P45M9 as a GSK Varicella/Shingles vaccine, received between 2018-07-13 and 2023-07-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
71
Reports
1%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7831%
General / Systemic (non-local)6526%
Neurological2610%
Musculoskeletal218%
Dermatological (non-injection-site)166%
Allergic / Anaphylactic156%
Gastrointestinal156%
Cardiac / Cardiovascular94%
Psychiatric / Neuropsychiatric31%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%
Respiratory10%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
Illinois5
New York5
Florida4
Pennsylvania3
Missouri3
Virginia3
Michigan3
New Jersey3
Texas3
Minnesota2
Colorado2

Reports by month received

2018-071
2018-084
2018-0941
2018-1012
2018-112
2018-125
2019-012
2019-021
2019-071
2019-091
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.